PEDIATRICS Vol. 82 No. 2 August 1988, pp. 199-203
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Groothuis, J. R.
Right arrow Articles by Lauer, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Groothuis, J. R.
Right arrow Articles by Lauer, B. A.

Respiratory Syncytial Virus Infection in Children With Bronchopulmonary Dysplasia

Jessie R. Groothuis MD1, Kathleen M. Gutierrez MD1, and Brian A. Lauer MD1

1 From the Department of Pediatrics, University of Colorado School of Medicine, Denver

Little is known about the risk of severe illness from respiratory syncytial virus infection in children with bronchopulmonary dysplasia. A prospective study was done of the natural history of respiratory syncytial virus infection in 30 children <2 years of age with bronchopulmonary dysplasia who were in a home oxygen program. Surveillance to identify children with acute respiratory symptoms was done by weekly telephone interview. Symptomatic children were examined, oxygen saturation was determined by oximetry, and nasopharyngeal lavage fluid was collected for virus cultures and rapid respiratory syncytial virus antigen tests. During the 4-month study period (December to April), 27 children had one or more acute respiratory illnesses, and respiratory syncytial virus developed in 16/27 (59%). Passive smoking and gefour members in the home increased the risk of symptomatic respiratory syncytial virus (P < .01 and P < .03, respectively). Of 16 children, 11 (69%) required hospitalization. Of the 11 hospitalized children with respiratory syncytial virus, nine were either still receiving oxygen at home or required oxygen therapy within the previous 3 months v none of five nonhospitalized children (P < .005). Five of the hospitalized children were >12 months of age and five had respiratory syncytial virus infection previously that had been confirmed by culture results. Hospitalizations were prolonged and complicated. Seven of 11 children were hospitalized for >1 week; four were admitted to the intensive care unit; four were treated with ribavirin aerosol, and two needed mechanical ventilation. There were no deaths. We conclude that respiratory syncytial virus infection is a major cause of acute respiratory deterioration and rehospitalization in young children with bronchopulmonary dysplasia, particularly those with current or recent supplemental oxygen requirements.

Key Words: respiratory syncytial virus • bronchopulmonary dysplasia

Submitted on July 16, 1987
Accepted on November 6, 1987




This article has been cited by other articles:


Home page
 J Trop PediatrHome page
M. Howidi, J. Rajah, Z. Abushrar, and H. Parsons
The Severity of Respiratory Syncytial Virus Bronchiolitis in Young Infants in the United Arab Emirates
J Trop Pediatr, February 1, 2007; 53(1): 22 - 26.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. M. Castro, A. Guerrero-Plata, G. Suarez-Real, P. A. Adegboyega, G. N. Colasurdo, A. M. Khan, R. P. Garofalo, and A. Casola
Antioxidant Treatment Ameliorates Respiratory Syncytial Virus-induced Disease and Lung Inflammation
Am. J. Respir. Crit. Care Med., December 15, 2006; 174(12): 1361 - 1369.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
X. Zhao, E. Liu, F.-P. Chen, and W. M. Sullender
In Vitro and In Vivo Fitness of Respiratory Syncytial Virus Monoclonal Antibody Escape Mutants
J. Virol., December 1, 2006; 80(23): 11651 - 11657.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
L. G. Stensballe, K. Kristensen, E. A.F. Simoes, H. Jensen, J. Nielsen, C. S. Benn, P. Aaby, and for the Danish RSV Data Network
Atopic Disposition, Wheezing, and Subsequent Respiratory Syncytial Virus Hospitalization in Danish Children Younger Than 18 Months: A Nested Case-Control Study
Pediatrics, November 1, 2006; 118(5): e1360 - e1368.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
L. K. Washburn, P. A. Nixon, and T. M. O'Shea
Follow-up of a Randomized, Placebo-Controlled Trial of Postnatal Dexamethasone: Blood Pressure and Anthropometric Measurements at School Age
Pediatrics, October 1, 2006; 118(4): 1592 - 1599.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
Subcommittee on Diagnosis and Management of Bronch
Diagnosis and Management of Bronchiolitis
Pediatrics, October 1, 2006; 118(4): 1774 - 1793.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. A. Choudhuri, L. G. Ogden, A. J. Ruttenber, D. S.K. Thomas, J. K. Todd, and E. A.F. Simoes
Effect of Altitude on Hospitalizations for Respiratory Syncytial Virus Infection
Pediatrics, February 1, 2006; 117(2): 349 - 356.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. Prais, D. Danino, T. Schonfeld, J. Amir, and for the Israeli RSV Monitoring Group
Impact of Palivizumab on Admission to the ICU for Respiratory Syncytial Virus Bronchiolitis: A National Survey
Chest, October 1, 2005; 128(4): 2765 - 2771.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
N. K. Leidy, M. K. Margolis, J. P. Marcin, J. A. Flynn, L. R. Frankel, S. Johnson, D. Langkamp, and E. A. F. Simoes
The Impact of Severe Respiratory Syncytial Virus on the Child, Caregiver, and Family During Hospitalization and Recovery
Pediatrics, June 1, 2005; 115(6): 1536 - 1546.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
T Heikkinen, H Valkonen, L Lehtonen, R Vainionpaa, and O Ruuskanen
Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2005; 90(1): F64 - F68.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. R. Brasier, H. Spratt, Z. Wu, I. Boldogh, Y. Zhang, R. P. Garofalo, A. Casola, J. Pashmi, A. Haag, B. Luxon, et al.
Nuclear Heat Shock Response and Novel Nuclear Domain 10 Reorganization in Respiratory Syncytial Virus-Infected A549 Cells Identified by High-Resolution Two-Dimensional Gel Electrophoresis
J. Virol., November 1, 2004; 78(21): 11461 - 11476.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. D. Schreiber, K. Gin-Mestan, J. D. Marks, D. Huo, G. Lee, and P. Srisuparp
Inhaled Nitric Oxide in Premature Infants with the Respiratory Distress Syndrome
N. Engl. J. Med., November 27, 2003; 349(22): 2099 - 2107.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Singleton, N. Etchart, S. Hou, and L. Hyland
Inability To Evoke a Long-Lasting Protective Immune Response to Respiratory Syncytial Virus Infection in Mice Correlates with Ineffective Nasal Antibody Responses
J. Virol., November 1, 2003; 77(21): 11303 - 11311.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
D. Prais, T. Schonfeld, and J. Amir
Admission to the Intensive Care Unit for Respiratory Syncytial Virus Bronchiolitis: A National Survey Before Palivizumab Use
Pediatrics, September 1, 2003; 112(3): 548 - 552.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
F. Esper, D. Boucher, C. Weibel, R. A. Martinello, and J. S. Kahn
Human Metapneumovirus Infection in the United States: Clinical Manifestations Associated With a Newly Emerging Respiratory Infection in Children
Pediatrics, June 1, 2003; 111(6): 1407 - 1410.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
S. Kamal-Bahl, J. Doshi, and J. Campbell
Economic Analyses of Respiratory Syncytial Virus Immunoprophylaxis in High-Risk Infants: A Systematic Review
Arch Pediatr Adolesc Med, October 1, 2002; 156(10): 1034 - 1041.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
A Greenough, S Cox, J Alexander, W Lenney, F Turnbull, S Burgess, P A J Chetcuti, N J Shaw, A Woods, J Boorman, et al.
Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection
Arch. Dis. Child., December 1, 2001; 85(6): 463 - 468.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. S. Kahn, A. Roberts, C. Weibel, L. Buonocore, and J. K. Rose
Replication-Competent or Attenuated, Nonpropagating Vesicular Stomatitis Viruses Expressing Respiratory Syncytial Virus (RSV) Antigens Protect Mice against RSV Challenge
J. Virol., November 15, 2001; 75(22): 11079 - 11087.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. Casola, R. P. Garofalo, H. Haeberle, T. F. Elliott, R. Lin, M. Jamaluddin, and A. R. Brasier
Multiple cis Regulatory Elements Control RANTES Promoter Activity in Alveolar Epithelial Cells Infected with Respiratory Syncytial Virus
J. Virol., July 15, 2001; 75(14): 6428 - 6439.
[Abstract] [Full Text]

Home page
 ThoraxHome page
E Eber and M S Zach
Paediatric origins of adult lung disease {bullet} 8: Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy)
Thorax, April 1, 2001; 56(4): 317 - 323.
[Full Text]

Home page
 J. Clin. Microbiol.Home page
A. H. Brandenburg, R. van Beek, H. A. Moll, A. D. M. E. Osterhaus, and E. C. J. Claas
G Protein Variation in Respiratory Syncytial Virus Group A Does Not Correlate with Clinical Severity
J. Clin. Microbiol., October 1, 2000; 38(10): 3849 - 3852.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child.Home page
S. J Clark, M. W Beresford, N V Subhedar, and N J Shaw
Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort
Arch. Dis. Child., October 1, 2000; 83(4): 313 - 316.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
M. Thomas, A. Bedford-Russell, and M. Sharland
Hospitalisation for RSV infection in ex-preterm infants---implications for use of RSV immune globulin
Arch. Dis. Child., August 1, 2000; 83(2): 122 - 127.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
W. LENNEY;, C. CARNEGIE;, and H. MARCOVITCH
Palivizumab and RSV prevention
Arch. Dis. Child., July 1, 2000; 83(1): 87a - 87.
[Full Text]

Home page
 J. Immunol.Home page
A. Casola, R. P. Garofalo, M. Jamaluddin, S. Vlahopoulos, and A. R. Brasier
Requirement of a Novel Upstream Response Element in Respiratory Syncytial Virus-Induced IL-8 Gene Expression
J. Immunol., June 1, 2000; 164(11): 5944 - 5951.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
T. P. Stevens, R. A. Sinkin, C. B. Hall, W. M. Maniscalco, and K. M. McConnochie
Respiratory Syncytial Virus and Premature Infants Born at 32 Weeks' Gestation or Earlier: Hospitalization and Economic Implications of Prophylaxis
Arch Pediatr Adolesc Med, January 1, 2000; 154(1): 55 - 61.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
S. Joffe, G. J. Escobar, S. B. Black, M. A. Armstrong, and T. A. Lieu
Rehospitalization for Respiratory Syncytial Virus Among Premature Infants
Pediatrics, October 1, 1999; 104(4): 894 - 899.
[Abstract] [Full Text]

Home page
 PediatricsHome page
S. Joffe, G. T. Ray, G. J. Escobar, S. B. Black, and T. A. Lieu
Cost-effectiveness of Respiratory Syncytial Virus Prophylaxis Among Preterm Infants
Pediatrics, September 1, 1999; 104(3): 419 - 427.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
G. J. Redding, S. Braun, and D. Mayock
Impact of Respiratory Syncytial Virus Immune Globulin in 1996-1997: A Local Controlled Comparison
Arch Pediatr Adolesc Med, May 1, 1999; 153(5): 503 - 507.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
F. W. MOLER and S. E. OHMIT
Severity Of Illness Models For Respiratory Syncytial Virus-Associated Hospitalization
Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1234 - 1240.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
S. C. Eppes;, S. L. Lee, J. L. Robinson;, E. M. Connor, D. Carlin, F. H. Top Jr, and L. E. Weisman
Questions About Palivizumab (Synagis)
Pediatrics, February 1, 1999; 103(2): 534 - 535.
[Full Text]

Home page
 PediatricsHome page
Committee on Infectious Diseases and Committee on
Prevention of Respiratory Syncytial Virus Infections: Indications for the Use of Palivizumab and Update on the Use of RSV-IGIV
Pediatrics, November 1, 1998; 102(5): 1211 - 1216.
[Abstract] [Full Text]

Home page
 Clin. Microbiol. Rev.Home page
R. A. Dudas and R. A. Karron
Respiratory Syncytial Virus Vaccines
Clin. Microbiol. Rev., July 1, 1998; 11(3): 430 - 439.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Jamaluddin, A. Casola, R. P. Garofalo, Y. Han, T. Elliott, P. L. Ogra, and A. R. Brasier
The Major Component of Ikappa Balpha Proteolysis Occurs Independently of the Proteasome Pathway in Respiratory Syncytial Virus-Infected Pulmonary Epithelial Cells
J. Virol., June 1, 1998; 72(6): 4849 - 4857.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
W. J. Rodriguez, W. C. Gruber, J. R. Groothuis, E. A. F. Simoes, A. J. Rosas, M. Lepow, A. K. , V. Hemming, and the RSV-IGIV Study Group
Respiratory Syncytial Virus Immune Globulin Treatment of RSV Lower Respiratory Tract Infection in Previously Healthy Children
Pediatrics, December 1, 1997; 100(6): 937 - 942.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. M. Langley, J. C. LeBlanc, E. E. L. Wang, B. J. Law, N. E. MacDonald, I. Mitchell, D. Stephens, J. McDonald, F. D. Boucher, and S. Dobson
Nosocomial Respiratory Syncytial Virus Infection in Canadian Pediatric Hospitals: A Pediatric Investigators Collaborative Network on Infections in Canada Study
Pediatrics, December 1, 1997; 100(6): 943 - 946.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
J. N Fletcher, R. L Smyth, H. M Thomas, D Ashby, and C A. Hart
Respiratory syncytial virus genotypes and disease severity among children in hospital
Arch. Dis. Child., December 1, 1997; 77(6): 508 - 511.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child.Home page
A. H Brandenburg, P.-Y. Jeannet, H. A v Steensel-Moll, A. Ott, P. H Rothbarth, W. Wunderli, S. Suter, H. J Neijens, A. D M E Osterhaus, and C.-A. Siegrist
Local variability in respiratory syncytial virus disease severity
Arch. Dis. Child., November 1, 1997; 77(5): 410 - 414.
[Abstract] [Full Text]

Home page
 PediatricsHome page
H. C. Meissner and J. R. Groothuis
Immunoprophylaxis and the Control of RSV Disease
Pediatrics, August 1, 1997; 100(2): 260 - 260.
[Full Text] [PDF]

Home page
 PediatricsHome page
Committee on Infectious Diseases and Committee on Fetus and Newborn
Respiratory Syncytial Virus Immune Globulin Intravenous: Indications for Use
Pediatrics, April 1, 1997; 99(4): 645 - 650.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
B. J. Law, E. E. L. Wang, N. MacDonald, J. McDonald, S. Dobson, F. Boucher, J. Langley, J. Robinson, I. Mitchell, and D. Stephens
Does Ribavirin Impact on the Hospital Course of Children With Respiratory Syncytial Virus (RSV) Infection? An Analysis Using the Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) RSV Database
Pediatrics, March 1, 1997; 99(3): e7 - e7.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
W. J. Rodriguez, W. C. Gruber, R. C. Welliver, J. R. Groothuis, E. A. F. Simoes, H. C. Meissner, V. G. Hemming, C. B. Hall, M. L. Lepow, A. J. Rosas, et al.
Respiratory Syncytial Virus (RSV) Immune Globulin Intravenous Therapy for RSV Lower Respiratory Tract Infection in Infants and Young Children at High Risk for Severe RSV Infections
Pediatrics, March 1, 1997; 99(3): 454 - 461.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
R L Smyth, J N Fletcher, H M Thomas, and C A Hart
Immunological responses to respiratory syncytial virus infection in infancy
Arch. Dis. Child., March 1, 1997; 76(3): 210 - 214.
[Abstract] [Full Text]

Home page
 PediatricsHome page
The PREVENT Study Group
Reduction of Respiratory Syncytial Virus Hospitalization Among Premature Infants and Infants With Bronchopulmonary Dysplasia Using Respiratory Syncytial Virus Immune Globulin Prophylaxis
Pediatrics, January 1, 1997; 99(1): 93 - 99.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. R. Groothuis, E. Simoes, M. J. Levin, C. B. Hall, C. E. Long, W. J. Rodriguez, J. Arrobio, H. C. Meissner, D. R. Fulton, R. C. Welliver, et al.
Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children
N. Engl. J. Med., November 18, 1993; 329(21): 1524 - 1530.
[Abstract] [Full Text]

Home page
 NEJMHome page
K. McIntosh
Respiratory Syncytial Virus -- Successful Immunoprophylaxis at Last
N. Engl. J. Med., November 18, 1993; 329(21): 1572 - 1574.
[Full Text]